AI-generated summary
This randomized clinical trial of 37 head and neck cancer patients receiving radiotherapy reported that photobiomodulation with an 810 nm infrared diode laser was associated with more stimulated saliva at week six and less subjective xerostomia at weeks four to six compared with a sham laser. The authors called for larger studies with more sessions before firm conclusions can be drawn.
- Participants
- 37
- Who or what was studied
- Adults with head and neck cancer referred for radiotherapy at a cancer center in Mashhad; 26 men and 11 women with a mean age of 55.6 years.
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The authors state that a higher sample size and more laser sessions are needed for definitive comment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 2.85 J/cm2, 45.6 J/cm2
- Power
- 200 mW
- Total energy
- 0.8 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Control group, Sample size, Wavelength, Dose, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.